Market Overview

Teva Launches Generic Viagra in Europe

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) announced today that it
had launched a generic version of Viagra® (sildenafil) immediately on
patent expiry in Germany, the United Kingdom, Italy, the Netherlands,
Switzerland, Ireland, Austria, Belgium and Denmark. The company had
already launched the product in Spain, Canada and certain other
countries.

Dipankar Bhattacharjee, President and CEO Europe Generics, welcomed the
launch: “Teva has a proud track record of bringing high-quality generics
to the market on day one of patent expiry, and we have been able to
launch sildenafil immediately on patent expiry in all the major markets
of Europe. The launch today of sildenafil will bring choice to the
pharmacy to help them serve the patient, and

See full press release

Posted-In: News Guidance Contracts Asset Sales Management Global

 

Related Articles (TEVA)

Around the Web, We're Loving...

Get Benzinga's Newsletters